Potentiation of the anaphylatoxins in vivo using an inhibitor of serum carboxypeptidase N (SCPN). I. Lethality and pathologic effects on pulmonary tissue.
about
Mechanism of action of the group A streptococcal C5a inactivatorDifferential effects of the complement peptides, C5a and C5a des Arg on human basophil and lung mast cell histamine release.Activation of C5 by cobra venom factor is required in neutrophil-mediated lung injury in the rat.Targeted disruption of the gene encoding the murine small subunit of carboxypeptidase N (CPN1) causes susceptibility to C5a anaphylatoxin-mediated shock.C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activationStructure and function of human plasma carboxypeptidase N, the anaphylatoxin inactivatorThe role of the complement system in acute kidney injury.Abrogation of immune complex glomerulonephritis by native carboxypeptidase and pharmacological antagonism of the C5a receptor.Complement activation: an emerging player in the pathogenesis of cardiovascular diseaseAn analysis of functional activity via the three complement pathways during hemodialysis sessions: a new insight into the association between the lectin pathway and C5 activation.Plasmin alters the activity and quaternary structure of human plasma carboxypeptidase N.Design and biological activity of a new generation of synthetic C3a analogues by combination of peptidic and non-peptidic elements.In vivo effects of monoclonal antibodies that functionally inhibit complement regulatory proteins in rats.
P2860
Q24608674-E42C973B-B724-48F1-8CC1-437387B5F7B3Q35586919-DFC9852F-A4C9-4B54-8446-ABA996E47105Q35856223-61AC1A3F-C3A4-4EB7-BE54-014FD303FC23Q35882816-D43826BE-45B8-4721-AD43-36C8BD817EA6Q36364952-04C280E6-2DBD-4F3E-8A0F-0657631A9F6BQ37015009-B3A73E66-8D5E-4DA6-A925-3F5E190A71F8Q37275159-16FDB155-B90E-47F5-A60E-F816B297B7D1Q37285007-D3B72C53-802C-479E-99FB-B5ED1695320DQ37288362-E5AED7F0-EDEC-4210-A608-97B9A0799F64Q40684322-93739612-AC1E-42EE-B352-9836B4C8C49BQ41817079-067A3D7C-0427-41A0-AC06-2A13B448E9ECQ42818254-675F6C13-5DCC-45E6-9BB8-410D067A2448Q42942657-C7AC18E5-AF27-422E-A962-46EA488399E0
P2860
Potentiation of the anaphylatoxins in vivo using an inhibitor of serum carboxypeptidase N (SCPN). I. Lethality and pathologic effects on pulmonary tissue.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年学术文章
@wuu
1983年学术文章
@zh-cn
1983年学术文章
@zh-hans
1983年学术文章
@zh-my
1983年学术文章
@zh-sg
1983年學術文章
@yue
1983年學術文章
@zh
1983年學術文章
@zh-hant
name
Potentiation of the anaphylato ...... c effects on pulmonary tissue.
@ast
Potentiation of the anaphylato ...... c effects on pulmonary tissue.
@en
type
label
Potentiation of the anaphylato ...... c effects on pulmonary tissue.
@ast
Potentiation of the anaphylato ...... c effects on pulmonary tissue.
@en
prefLabel
Potentiation of the anaphylato ...... c effects on pulmonary tissue.
@ast
Potentiation of the anaphylato ...... c effects on pulmonary tissue.
@en
P2093
P2860
P1476
Potentiation of the anaphylato ...... c effects on pulmonary tissue.
@en
P2093
P2860
P407
P577
1983-07-01T00:00:00Z